Washington, D.C. (January 20, 2011) – Pharmaceutical Research and Manufacturers of America (PhRMA) Executive Vice President for Advocacy Chip Davis released the following statement regarding the United States and China public-private partnership on healthcare.
“The Pharmaceutical Research and Manufacturers of America (PhRMA) applauds the efforts of the U.S. Trade and Development Agency (USTDA), the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Commerce (Commerce) in joining with China’s Ministries of Health (MoH) and Commerce (MOFCOM) to announce their support for the establishment a new public-private partnership in the healthcare sector.
“This partnership will provide good opportunities to appropriately promote U.S. exports as well as highlight the importance of the private sector and governments working collaboratively to improve health systems and patient access to life-saving and life enhancing goods and services. PhRMA is proud to be a supporter of this initiative and looks forward to working with both governments and other partners in the private sector to find ways to better meet the healthcare needs of both countries.
“While many of the details are to be worked out, we believe the partnership will create new opportunities for interactions between the regulators in China and the United States. Such interactions and information sharing help to improve efficiencies that can ensure products reach patients quickly and safely. PhRMA also welcomes the opportunity for a more open dialogue with healthcare stakeholders in China about how we can all support China's healthcare goals of ensuring safe, efficient, convenient and affordable healthcare for its citizens."
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.
PhRMA Internet Address: www.phrma.org
For information on stories of hope and survival, visit: http://sharingmiracles.com/
For information on how innovative medicines save lives, visit: www.innovation.org
For information on the Partnership for Prescription Assistance, visit: www.pparx.org
For more information on public health emergencies, visit: www.rxresponse.org